Overview
Kevin Weinfurt, Ph.D., is the James B. Duke Distinguished Professor and Vice Chair of Faculty in the Department of Population Health Sciences at Duke University Medical Center. Dr. Weinfurt also holds faculty appointments in Psychology and Neuroscience, Philosophy, Psychiatry and Behavioral Sciences, Biostatistics and Bioinformatics, the Duke Clinical Research Institute, and the Trent Center for Bioethics, Humanities & History of Medicine. Dr. Weinfurt worked part-time for four years as a Special Governmental Employee with the U.S. Food and Drug Administration, developing guidance for the Patient-Focused Drug Development initiative. Dr. Weinfurt received his PhD in psychology at Georgetown University and did graduate work in the history of science and philosophy of mind at Linacre College, Oxford.
Dr. Weinfurt researches clinical outcome assessments, pragmatic trial methodology, and bioethics. Currently, Dr. Weinfurt is co-PI of the coordinating center for the NIH Health Systems Research Collaboratory, which is dedicated to improving understanding of how to conduct pragmatic clinical trials. Within the NIH Collaboratory, he has led or co-led work on bioethics, patient-reported outcomes, and disseminating lessons learned. He is currently an Associate Editor of Clinical Trials. He served on the Board of Directors for the International Society of Quality of Life Research and was a member of the Patient-Centered Outcomes Research Institute’s Clinical Trials Advisory Panel. Dr. Weinfurt served as a member of the Secretary’s Advisory Committee on Human Research Protections (SACHRP), which provides expert advice and recommendations to the Secretary of HHS on issues pertaining to protecting human subjects in research.
As an educator, Dr. Weinfurt has taught undergraduate and graduate courses in bioethics, health measurement, psychology, and research methods.
Areas of Expertise: Bioethics, Health Measurement, Health Services Research, and Health Behavior
Current Appointments & Affiliations
Recent Publications
Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.
Journal Article Hum Gene Ther · May 2026 Developing gene therapies involving gene editing is a rapidly evolving field with large potential implications for improving health for both rare and common diseases. Ensuring that these technologies are developed safely, efficiently, and fairly is essenti ... Full text Link to item CiteThe structural and moral integrity of our field.
Journal Article J Patient Rep Outcomes · April 10, 2026 This commentary consists of edited remarks made by the author upon receipt of the 2025 International Society for Quality of Life Research President’s Award. The field of health measurement/quality-of-life research is viewed as a house in which we have grow ... Full text Link to item CiteImpact of Legal Perceptions and Disclosure on Willingness to Undergo HIV Antiretroviral Resistance Testing Among Men Who Have Sex with Men: A Brief Report.
Journal Article AIDS Behav · March 24, 2026 Human Immunodeficiency Virus (HIV) criminalization laws may discourage engagement in care. American Men's Internet Survey participants were randomized to disclosure, in which automatic public health reporting of antiretroviral resistance testing (ARVRT) wa ... Full text Link to item CiteRecent Grants
ASCENT: Advancing the Science of palliative Care rEsearch across the lifespaN
ResearchCo Investigator · Awarded by University of Colorado Anschutz Medical Campus · 2025 - 2030Nurse LEADS: Training in Nurse-LEd models of care ADdressing the Social Determinants of Health
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Nursing Research · 2024 - 2029UrogynCREST Program
ResearchCourse Faculty · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019 - 2029View All Grants